Key result
Isoproterenol suppresses LPS-induced cardiac TNF-alpha release ~97% in isolated rat hearts.
Why the study?
Beta-adrenergic receptor agonists such as isoproterenol inhibit TNF-alpha production in various cell types, and because the heart is a source of TNF-alpha, it was hypothesized that isoproterenol would inhibit cardiac production of the cytokine.
Does isoproterenol inhibit LPS-stimulated TNF-alpha release in isolated rat hearts?
Does isoproterenol inhibit LPS-stimulated TNF-alpha release in isolated rat hearts?
Absolute Event Rate: 58% vs 2164%
p-value: p=<0.05
Activation of beta-adrenergic receptors inhibits cardiac TNF-alpha release, suggesting that impaired sympathetic response in heart failure may contribute to elevated TNF-alpha levels.
Beta-adrenergic stimulation may suppress cardiac TNF-alpha in endotoxemia; leaves open contribution of sympathetic impairment to cytokine elevation in human HF.
Objectives Beta-adrenergic receptor agonists such as isoproterenol inhibit production of tumor necrosis factor (TNF)-alpha in a number of cell types. Because the heart is a source of TNF-alpha, we hypothesized that isoproterenol would inhibit cardiac production of the cytokine. Design Analysis of cardiac release of TNF-alpha. Setting Medical research laboratory. Subjects Rats. Interventions None. Measurements and main results With the approval of the Institutional Animal Care and Use Committee, rats were anesthetized and hearts were removed and perfused. After 30 mins, bacterial lipopolysaccharide (LPS) with or without isoproterenol was infused for 60 mins. At 30, 60, 90, 120, and 150 mins, coronary flow was measured and coronary effluent was analyzed for TNF-alpha. Cardiac production of TNF-alpha was expressed as pg/min. Cyclic adenosine monophosphate (AMP) in the coronary effluent was measured. TNF-alpha messenger RNA was determined in ventricular tissue. After 30 mins, TNF-alpha was undetectable in the coronary effluent However, 60 mins after the initiation of LPS infusion, TNF-alpha release was 875+/-255 pg/min and increased to 2164+/-721 pg/min at 150 mins. Simultaneous infusion of isoproterenol with LPS stimulated cyclic AMP release and inhibited TNF-alpha production. For instance, at 60 and 150 mins, TNF-alpha release was 75+/-38 and 58+/-29 pg/min, respectively (p < .05 vs. LPS alone). Simultaneous infusion of isoproterenol with LPS blocked the induction of TNF-alpha messenger RNA by LPS. Isoproterenol, begun 30 mins after the initiation of LPS infusion, still suppressed LPS-stimulated TNF-alpha release by 95% at 150 mins. Similar results were obtained with norepinephrine. Conclusions Activation of beta-adrenergic receptors inhibits cardiac TNF-alpha release. This implies that cytokine production by the heart is inhibited by the sympathetic nervous system. In heart failure, the cardiac response to the sympathetic nervous system is impaired. This impairment may play a role in the high plasma levels of TNF-alpha found in heart failure.
No takes yet. Share an insight, caveat, or question.
Newman et al. (2000) studied LPS-induced cardiac TNF-alpha release (isolated rat hearts). Isoproterenol (with LPS) vs. LPS alone was evaluated on Cardiac TNF-alpha release in coronary effluent at 150 minutes (pg/min) (p=<0.05). Isoproterenol infusion inhibited LPS-induced cardiac TNF-alpha release in isolated rat hearts at 150 minutes (58 vs 2164 pg/min; p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: